Combination antifungal therapy for cryptococcal meningitis
about
The rise of multiple imputation: a review of the reporting and implementation of the method in medical researchFlucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungalIntegrated therapy for HIV and cryptococcosisCryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisA prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, MalawiPrimary cutaneous cryptococcosis treated with debridement and fluconazole monotherapy in an immunosuppressed patient: a case report and review of the literatureCryptococcal meningitis: A neglected NTD?High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, TanzaniaTiming of antiretroviral therapy after diagnosis of cryptococcal meningitis.AIDS-related mycoses: the way forward.Update on opportunistic infections in the era of effective antiretroviral therapyExploiting innate immune cell activation of a copper-dependent antimicrobial agent during infection.Antifungal clinical trials and guidelines: what we know and do not knowEfficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.Evaluation and treatment of chronic meningitis.High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal MeningitisCryptococcosis diagnosis and treatment: What do we know nowPlasma Membrane Proteolipid 3 Protein Modulates Amphotericin B Resistance through Sphingolipid Biosynthetic Pathway.Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifenTreatment principles for Candida and Cryptococcus.Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.Cryptococcal Meningitis: Diagnosis and Management Update.Outcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality.Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal ActivityPrevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South AfricaEarly Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence.Estimating the burden of fungal disease in Vietnam.Molecular diagnosis of invasive mycoses of the central nervous system.Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
P2860
Q26828889-E0E02878-788B-4866-A072-F43D151AC4C2Q27012487-A87A1AB5-BE82-4B23-9520-8385BC176769Q28077707-53EDD2CC-FFE8-4254-8251-45C0F3362E08Q28274334-37591C07-0AFC-424F-BD3B-8E3EA31B507DQ28534417-37197A7E-50FB-4AA3-86C2-A14B3BDA72B7Q30300532-39587CBA-FF1F-49AF-B55C-19940E82814CQ33852819-8297CB65-183B-4EA1-98A9-0BA33201DC22Q33875911-65FD757D-5B5E-401C-A037-45B73AFDC0A6Q34024241-892652A4-7AE3-4F8F-8E26-2ACA84FF8AE4Q34024416-2E36EDF2-E208-4F7C-BB2D-4ED3F0F7CCEEQ34030928-1FDBC623-1784-4A3C-9256-69F8259D9CA4Q34085853-A01C05BC-DA8F-496A-A3B4-548A36EF3B0DQ34219760-49EDD227-1283-4CB8-A79A-DA0E0DF9DAC1Q34400255-F65DFD94-7E06-4D7C-920C-B8FB63FA29B3Q34415736-B1F4B8AB-FBD6-4DAF-BB34-C126D046155EQ34418500-75546472-0653-4CE0-9356-2AD53EE4C18AQ34519945-5D55163D-238F-4A7C-9383-78ED6081AD30Q34540684-ACFD6CDE-049B-45BE-8E68-E611F066124EQ34801921-2D0B3411-5459-4E4D-94FC-A9C276F59485Q34895613-5DAD37CA-80B1-47B2-B2CA-60A21BE68D7CQ35092521-F5285E6F-426F-4702-8103-1F758C68B270Q35097032-557931E5-082C-47DF-B5E5-D12D22FE402DQ35230534-320EA377-62CC-4A61-8511-CB6AE6967F27Q35395169-6B7F2B70-AAA4-4190-BA33-A7D97C405D19Q35596158-799F2A4A-426A-48FF-B05F-DC78609ABA66Q35628245-E75DF27E-CDE3-4C07-9FA2-97FAA55744C4Q35643319-1781861F-FBA0-430A-A6D2-A9E107747ED2Q35664186-B6B75184-7033-4238-B265-CA544940D6B4Q35717560-E17A8FC0-640A-4CF9-81A6-91FEB9A8B41CQ35776693-C38208AB-A263-4704-BDA7-7E12CC2E801BQ35911359-82C0D3B4-5463-4AAC-9444-B8A3E5A7C761Q35919786-2F37C79E-BE46-4657-8F89-75C6A58FBAC0Q35951094-080D73A4-78E5-4F29-9E09-0AE1EF873FBCQ35984938-27CCF474-333F-4EF9-8E98-C61F4D350EF3Q36059265-ECB52FBB-13F9-4005-93B2-D3B8AA421FE3Q36088679-C460E48C-436E-4D41-A7A8-07B8F4903BFEQ36094655-CE352747-0569-405D-82ED-30E89F2B56A5Q36164298-C86CB65C-0596-402F-838E-B9E3854BCEADQ36218994-1B1656D2-0D8F-4105-9924-DF73D14953FAQ36290487-A663C102-E009-4CD5-ADF2-20167590F46C
P2860
Combination antifungal therapy for cryptococcal meningitis
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Combination antifungal therapy for cryptococcal meningitis
@en
type
label
Combination antifungal therapy for cryptococcal meningitis
@en
prefLabel
Combination antifungal therapy for cryptococcal meningitis
@en
P2093
P2860
P50
P356
P1476
Combination antifungal therapy for cryptococcal meningitis
@en
P2093
Cao Q Thai
Dinh X Sinh
Ho D Nghia
James I Campbell
Jeremy N Day
Ly V Chuong
Nguyen D Phong
Nguyen H Mai
Nguyen H Phu
P2860
P304
P356
10.1056/NEJMOA1110404
P407
P577
2013-04-01T00:00:00Z